TY - JOUR
T1 - Is telemedicine an answer to reducing 30-day readmission rates post-acute myocardial infarction?
AU - Ben-Assa, Eyal
AU - Shacham, Yacov
AU - Golovner, Michal
AU - Malov, Nomi
AU - Leshem-Rubinow, Eran
AU - Zatelman, Avivit
AU - Oren Shamir, Ayelet
AU - Rogowski, Ori
AU - Roth, Arie
PY - 2014/9/1
Y1 - 2014/9/1
N2 - Background: Patients hospitalized for an acute myocardial infarction (AMI) are at risk for early readmission. Readmission rates in the community reportedly reach approximately 20%, and 30-day readmission rates have become a quality-of-care marker. Telemedicine is one strategy for improving clinical outcomes by offering real-time biometrics tracking and rapid intervention. We retrospectively assessed the 30-day readmission rate of post-AMI members of a telemedicine system. Materials and Methods: All "SHL"-Telemedicine subscribers who sustained an AMI and those who became subscribers within 10 days from discharge post-AMI between 2009 and 2012 were assessed. Their files were reviewed for demographics, coronary risk factors, reasons for readmission, and discharge diagnoses. Results: In total, 897 suitable patients (mean age, 62±14 years; 81% males) were included. They had made 3,318 calls to the monitor center for consultation. A mobile intensive care unit was dispatched for 158 patients, 64 were transported to the hospital, and 52 (5.8%) were readmitted (10 patients were readmitted twice). Thirty-five readmissions were for noncardiac reasons. Twelve patients had acute coronary syndrome (11 were revascularized). Readmission rates were higher in patients with repeat AMIs (11.9% versus 5.3% among those with no AMI history) and in females (9.6% versus 4.9% among males). Unlike published figures for the general population, there were no significant differences between readmitted and non-readmitted patients regarding diabetes, hypertension, or congestive heart failure. Conclusions: Telemedicine technology shows considerable promise for reducing 30-day readmission rates of post-AMI patients.
AB - Background: Patients hospitalized for an acute myocardial infarction (AMI) are at risk for early readmission. Readmission rates in the community reportedly reach approximately 20%, and 30-day readmission rates have become a quality-of-care marker. Telemedicine is one strategy for improving clinical outcomes by offering real-time biometrics tracking and rapid intervention. We retrospectively assessed the 30-day readmission rate of post-AMI members of a telemedicine system. Materials and Methods: All "SHL"-Telemedicine subscribers who sustained an AMI and those who became subscribers within 10 days from discharge post-AMI between 2009 and 2012 were assessed. Their files were reviewed for demographics, coronary risk factors, reasons for readmission, and discharge diagnoses. Results: In total, 897 suitable patients (mean age, 62±14 years; 81% males) were included. They had made 3,318 calls to the monitor center for consultation. A mobile intensive care unit was dispatched for 158 patients, 64 were transported to the hospital, and 52 (5.8%) were readmitted (10 patients were readmitted twice). Thirty-five readmissions were for noncardiac reasons. Twelve patients had acute coronary syndrome (11 were revascularized). Readmission rates were higher in patients with repeat AMIs (11.9% versus 5.3% among those with no AMI history) and in females (9.6% versus 4.9% among males). Unlike published figures for the general population, there were no significant differences between readmitted and non-readmitted patients regarding diabetes, hypertension, or congestive heart failure. Conclusions: Telemedicine technology shows considerable promise for reducing 30-day readmission rates of post-AMI patients.
KW - acute myocardial infarction
KW - readmission
KW - telemedicine
UR - http://www.scopus.com/inward/record.url?scp=84906907100&partnerID=8YFLogxK
U2 - 10.1089/tmj.2013.0346
DO - 10.1089/tmj.2013.0346
M3 - Article
C2 - 25046174
AN - SCOPUS:84906907100
SN - 1530-5627
VL - 20
SP - 816
EP - 821
JO - Telemedicine and e-Health
JF - Telemedicine and e-Health
IS - 9
ER -